Beth Israel Lahey Health
Burlington, Massachusetts 01805
0 studies enrolling now · 1 studies all time
What they study most
Breast Cancer
Studies at this site
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
— Recruiting now